GOLM1 and autoimmune hepatitis: Our findings were consistent with a report from Iftikhar et al.19 Another study30 observed that serum GP73 levels were significantly reduced in patients with viral or autoimmune hepatitis in response to antiviral or immune-inhibitory therapy, and these authors suggest using GP73 as a marker to monitor the efficacy of hepatitis treatment.